Clearstead Advisors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Clearstead Advisors's ADPT Position: Q2 2026 in Review
Clearstead Advisors opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 223 shares worth $4.78K. The stake represents ﹤0.01% of the portfolio and ranks #2210 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in ADPT as recently as Q4 2025.
Clearstead Advisors first reported a position in ADPT in Q2 2021 and has held it in 6 quarters since. The position peaked at $60.9K in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Clearstead Advisors held 223 shares of Adaptive Biotechnologies worth $4.78K as of Q2 2026.
- Adaptive Biotechnologies was a new Clearstead Advisors position in Q2 2026.
- Adaptive Biotechnologies made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2210 holding.
- Clearstead Advisors first reported a position in Adaptive Biotechnologies in Q2 2021 and has held it in 6 quarters since.
- Clearstead Advisors's Adaptive Biotechnologies position peaked at $60.9K in Q4 2025.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.